ZMH-56450-15953
2 vaccinations
6 coded responses
20 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 087 / NJ
- Registered
- 2021-02-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-18
Dose 1 — Moderna
-
2021-02-21
Registered in v-safe
-
2021-02-21
Survey response — days 1–6 daily, dose 1MedDRA: Decreased appetite, Injection site swelling — Feeling: Fair · Site: Pain, RednessFree text: Swelling at site of injection and loss of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-24
- 2021-02-25
- 2021-03-04
- 2021-03-11
-
2021-03-17
Dose 2 — Moderna
- 2021-03-17
-
2021-03-18
Survey response — days 1–6 daily, dose 2MedDRA: Nonspecific reaction — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Couldnt lift heavy itemsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — days 1–6 daily, dose 2MedDRA: Body temperature increased, Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, SwellingFree text: Lymph node swelling and pain, elevated temp but not a feverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Redness, ItchingFree text: Swollen slightly painful lymph nodes and tonsilsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-31
-
2021-04-07
Survey response — day 21, dose 2MedDRA: Epistaxis, Nasal congestion, Sinus pain — Feeling: FairFree text: Stuffiness and frequent nosebleeds and sinus pain might be allergies or something else not sureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-06-19
-
2021-09-15
Survey response — 6 months, dose 2MedDRA: Ageusia, Anosmia, Breakthrough COVID-19, Fatigue, Myalgia, Oropharyngeal pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: For one week i had: fatigue, muscle pain, fever ranging from 101 to 99.5 deg f, throat pain, and loss of taste and smell. I could not get transportation to a test center even though i suspect it was covid breakthrough.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-18 | Moderna | |
| 2 | 2021-03-17 | Moderna |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Swelling at site of injection and loss of appetite
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Couldnt lift heavy items
Systemic reaction (other): Lymph node swelling and pain, elevated temp but not a fever
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen slightly painful lymph nodes and tonsils
Release 7 — day 21, dose 2
Symptoms: Stuffiness and frequent nosebleeds and sinus pain might be allergies or something else not sure
Release 9 — 6 months, dose 2
Symptoms: For one week i had: fatigue, muscle pain, fever ranging from 101 to 99.5 deg f, throat pain, and loss of taste and smell. I could not get transportation to a test center even though i suspect it was covid breakthrough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Breakthrough COVID-19 | · | · | ✓ |
| SD | Epistaxis | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Sinus pain | ✓ | ✓ | ✓ |
| SRO | Body temperature increased | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Nonspecific reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release